Drugs / Cortisol
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT01718964 | Nov 2012 → Jul 2013 | opiate dependence | University of Basel | Completed | Met primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT03558971 | Jan 2000 → Dec 2016 | rheumatic disorder | Helen Foundation | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT00362661 | Jun 2007 → Dec 2009 | post-traumatic stress disorder | University of Zurich | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT00451750 | May 2007 → Sep 2009 | phobic disorder | University of Zurich | Completed | No outcome recorded |
| — | NCT00759005 | Mar 2007 → Jun 2008 | heroin dependence | National Institute on Drug Dependence, China | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT04921189 Comparator | Dec 2021 → Dec 2024 | cardiac arrest, post-cardiac arrest syndrome | Asan Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT02196142 Comparator | Nov 2014 → Jun 2015 | alcohol dependence | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cortisol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00451750 ↗ |
| Action | Inhibit | “Cortisol has an inhibiting effect on alcohol craving and stress reactivity in alcohol dependent subjects.” NCT02196142 ↗ |
| Route | Oral | “A single oral dose of 20 mg of cortisol or placebo was administered” PMID 26218852 ↗ Jul 2015 |